11 results
Antiarrhythmic Medications - Vaughan Williams Classification - Summary Table
Class I agents - Sodium Channel Blockers⠀
Class II
Class I agents ... Channel Blockers⠀ Class ... agents in this class ... beta blockers.⠀ Class ... Channel Blockers Class
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... Each class of medications ... own benefits and risks ... the hypoglycemia risk ... pharmacotherapy #table
Clostridium Dificile Risk by Antibiotic Class

Pooled and study-specific risk estimates of community-associated CDI risk by antibiotic
by Antibiotic Class ... by antibiotic class ... #Pharmacology #Class ... #Clostridium #Table ... #Comparison #OddsRatio
Antiarrhythmics - Sodium Channel Blockers
Subclasses, Mechanisms, Indications, Side Effects
la - Quinidine, Procainamide
lb - Lidocaine, Mexiletine
Ic -
Subclasses, Mechanisms, Indications ... Channel #Blockers #ClassI ... #pharmacology #table ... #comparison
A priority in this project was to appropriately stratify participants into a low, medium, or high-intensity
group-based exercise class ... The classification ... for Fall Risk Assessment ... The algorithm is ... #Fall #Risk #Screening
American Society of Anesthesiologists (ASA) Classification
The ASA classification (Table) aims to predict perioperative mortality rates but
(Table) aims to ... Higher ASA class ... when an ASA class ... compared with an ASA class ... and when an ASA class
Type 2 Diabetes - Screening, Diagnosis and Management Algorithm
Lifestyle  Modifications (Diet and Exercise) -> Start
and Management Algorithm ... Modifications (Diet ... • Secondary Causes ... Rubella) • Medications ... #DM2 #DMII #Classification
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... ASA class If ... event, follow ACC algorithm ... Stable patients ... the type of and indication
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Roflumilast) Indication ... : Reduce risk of ... exacerbations Drug Class ... Dosing: 250 mcg tablet ... to reduce the risk
Indications for Implantable Cardioverter-Defibrillator (ICD) in Patients with Ischemic Heart Disease (IHD) to Prevent Sudden Cardiac
Indications for ... LVEF < 35%, NYHA class ... despite guideline-directed ... LVEF < 30%, NYHA class ... unstable VT • Stable